期刊文献+

自拟复心汤治疗心衰临床观察 被引量:5

Observation on Fuxin Decoction Treatment of Complex Heart Failure
下载PDF
导出
摘要 目的:观察自拟复心汤治疗心衰的临床疗效。方法:对144例心衰患者随机单盲分为治疗组72例,采用规范化治疗加自拟复心汤治疗;对照组72例,单用规范化治疗。结果:治疗组的心功能改善、左室射血分数(EF)明显好于对照组(P<0.05),具有统计学意义。两组左室舒张末直径(LVEDD)同治疗前比较均无显著性差异(P>0.05),无明显统计学差异。结论:加用自拟复心汤治疗心衰优于现代医学的规范化治疗。 Objective : To observe the clinical efficacy of Fuxin Decotion treating heart failure. Methods : 144 patients with heart failure were randomly divided into treatment group, in which 72 cases were treated with Fuxin Decoction ; control group, in which 72 cases were treated normally. Resuhs : The improvement of heart function and left ventricular ejection fraction ( EF ) in treatment group were significantly better than that in the control group ( P〈0.05 ), with statistical significance. The left ventricular end diastolic diameter ( LVEDD ) of two groups compared with before treatment respectively, there was no significant difference ( P〉0.05 ). Conclusion : The Fuxin Decoction treating complex heart failure has better effect than the standard treatment of modern medicine.
作者 姜钧文
出处 《辽宁中医药大学学报》 CAS 2012年第1期153-154,共2页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 心衰 中西医疗法 自拟复心汤 规范化治疗 heart failure TCM and western medicine therapy Fuxin Decoction standard treatment
  • 相关文献

参考文献3

二级参考文献16

  • 1张灼辉,谭健强.倍他乐克治疗充血性心力衰竭临床分析[J].中国现代医学杂志,2004,14(17):134-135. 被引量:12
  • 2吕爱莲,张宪南.卡维地洛对慢性心力衰竭患者心功能的影响[J].中国现代医学杂志,2004,14(23):146-147. 被引量:2
  • 3Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A.
  • 4Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162.
  • 5Packer M, Coats AJS, Fowler MB, et al. For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658.
  • 6Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J, 2001, 22: 1527-1561.
  • 7Hunt HA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2001, 104:2996-3007.
  • 8The Digital Investigation Group.The effect of digoxin on mortality and morbility in patients with heart failure[J].N Engl J Med,1997,336(8):525-533.
  • 9GLICK H,COOK J,KINOSIAN B,et al.Costs and effects of enalapril therapy in patients with symptomatic heart failure:an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial[J].J Card Fail,1995,1(5):371-380.
  • 10CONSENSUS Trial Study Group.Effect of enalapril on mortality in severe congestive heart failure:result of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)[J].N Engl J Med,1987,316(23):1429-1435.

共引文献376

同被引文献75

引证文献5

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部